Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
Recruiting · NCT06135571 · Observational (researchers observe without assigning treatment) · Lead sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this observational study is to learn about the the pattern of metastasis of the No.253 lymph node in colorectal cancer. The main questions it aims to answer are: 1. What are the risk factors for metastasis to the No.253 lymph node? 2.What is the prognosis for patients with metastasis to the No.253 lymph node? Patients with descending colon cancer, sigmoid colon cancer, and rectal cancer who undergo curative surgery with dissection of the No.253 lymph node are included in this study
Who can take part
Inclusion criteria
- Age: 18-75 years;
- Underwent laparoscopic left hemicolectomy, sigmoid colectomy, or rectal cancer radical surgery.
- Postoperative pathology confirmed as adenocarcinoma.
- No evidence of distant metastasis.
Exclusion criteria
- Previous history of malignant colorectal tumors.
- Patients who have undergone multiple abdominal-pelvic surgeries.
- Patients undergoing emergency surgery due to complications such as intestinal obstruction, intestinal perforation, or intestinal bleeding.
- Surgery did not achieve R0 resection.
- Patients with concurrent other malignant tumors or multiple primary colorectal cancers.
- Patients unwilling to sign an informed consent or follow the study protocol for follow-up.
Where it is running
4 locations listed.
- Peking Union Medical College Hospital - Beijing, Beijing Municipality, China
- China-Japan Friendship Hospital - Beijing, Beijing Municipality, China
- Beijing Cancer Hospital - Beijing, Beijing Municipality, China
- Chinese PLA General Hospital - Beijing, Beijng, China